HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Local Dynamics
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS

    Tag: #Global Trends

    Crescent and Kelun-Biotech Execute Double Deal to Swap Cancer Asset Rights

    08/12/2025 Published by vivi

    The pharmaceutical companies Crescent Biopharma (US-based) and Kelun-Biotech (China-based) have announced a strategic partnership to exchange licensing rights for two... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Trial Data Opens Door for Earlier Use of Lilly’s BTK Inhibitor

    08/12/2025 Published by vivi

    (ORLANDO) – At an American Society of Hematology (ASH) meeting, the pharmaceutical company Eli Lillypresented results from a critical head-to-head... Read more

    Category: Uncategorized
    Tags: #Global Trends

    AstraZeneca Expands Amyloidosis Collaboration with Deal Potentially Reaching $780 Million

    07/12/2025 Published by vivi

    Alexion Pharmaceuticals, the rare disease unit of AstraZeneca, has expanded its partnership with biotech company Neurimmune by licensing a second... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Major Funding Deal: Therapeutics Company Secures $275 Million Through Drug Royalty Agreement

    07/12/2025 Published by vivi

    A therapeutics company has announced a funding agreement worth $275 million with a financial fund specializing in pharmaceutical royalties. The... Read more

    Category: Uncategorized
    Tags: #Global Trends

    A New Breakthrough in Duchenne Muscular Dystrophy Treatment: Promising Phase 3 Trial Results

    07/12/2025 Published by vivi

    A therapeutics company has announced positive topline results from its pivotal Phase 3 HOPE-3 clinical trial, evaluating the efficacy of... Read more

    Category: Uncategorized
    Tags: #Global Trends

    European Authorities Clear Novel Autoimmune Therapy for Myasthenia Gravis

    06/12/2025 Published by vivi

    The European Commission has granted authorization for nipocalimab, an immunoglobulin G (IgG) receptor antagonist developed by Johnson & Johnson, for... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Vetter Managing Director to Retire Following Over Three Decades of Service

    05/12/2025 Published by vivi

    Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has announced the retirement of its Managing Director, Thomas Otto,... Read more

    Category: Uncategorized
    Tags: #Global Trends

    New Study Suggests Shingles Vaccine May Slow Cognitive Decline

    04/12/2025 Published by vivi

    A new follow-up study, published in the journal Cell, adds evidence that the shingles vaccine, a two-dose shot recommended for... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Bristol Myers Bolsters Scale of Cobenfy Trial After Discovery of Site Irregularities

    04/12/2025 Published by vivi

    Bristol Myers Squibb (BMS) has announced an extension and increased enrollment for its late-stage clinical trial, “ADEPT-2,” of the drug... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Posts pagination

    Previous page Page 1 … Page 25 Page 26 Page 27 … Page 29 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved